Associated Papers
Discriminating activating, deactivating and resistance variants in protein kinases.
Singh G et al.
Genome Medicine, 2025
Unraveling the germline inheritance of the JAK2F556V gene mutation in familial thrombocythemia: a comprehensive analysis of 11 family members and potential implications for surveillance.
Meggendorfer M et al.
Haematologica, 2025
JAK/STAT in human diseases: a common axis in immunodeficiencies and hematological disorders.
Djidjik R et al.
Frontiers in Immunology, 2025
Clinical forecasting of acute myeloid leukemia using ex vivo drug-sensitivity profiling.
Andersen AN et al.
Cell Reports Methods, 2023
Genetic background of thrombocytosis in mice mimicking hereditary thrombocytosis in humans.
Kimura H et al.
Platelets, 2023
Genetic basis and molecular profiling in myeloproliferative neoplasms.
Luque Paz D et al.
Blood, 2023
Molecular basis of JAK2 H608Y and H608N mutations in the pathology of acute myeloid leukemia.
Li F et al.
International Journal of Biological Macromolecules, 2023
Hereditary thrombocytosis: the genetic landscape.
Han EY et al.
British Journal of Haematology, 2021
Identification of a JAK2 FERM Domain Variant Associated With Hereditary Thrombocytosis.
Müller J et al.
Hemasphere, 2021
Germline JAK2 V617F mutation as a susceptibility gene causing myeloproliferative neoplasm in first-degree relatives.
Park HS et al.
Leukemia & Lymphoma, 2020
Germline genetic factors in the pathogenesis of myeloproliferative neoplasms.
Bellanné-Chantelot C et al.
Blood Reviews, 2020
Diagnostic workflow for hereditary erythrocytosis and thrombocytosis.
McMullin MF
Hematology. American Society of Hematology. Education Program, 2019
Concomitant and noncanonical JAK2 and MPL mutations in JAK2V617F- and MPLW515 L-positive myelofibrosis.
Schulze S et al.
Genes, Chromosomes & Cancer, 2019
Germline JAK2 L611S mutation in a child with thrombocytosis.
Aral B et al.
Haematologica, 2018
Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.
Rumi E et al.
British Journal of Haematology, 2017
Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms.
Rumi E et al.
Blood, 2017
Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis.
Plo I et al.
Frontiers in Endocrinology, 2017
Identification of MPL R102P Mutation in Hereditary Thrombocytosis.
Bellanné-Chantelot C et al.
Frontiers in Endocrinology, 2017
Hereditary erythrocytosis, thrombocytosis and neutrophilia.
Hong WJ et al.
Best Practice & Research. Clinical Haematology, 2014
A novel germline JAK2 mutation in familial myeloproliferative neoplasms.
Rumi E et al.
American Journal of Hematology, 2014
JAK2 mutations to the fore in hereditary thrombocythemia.
Langabeer SE
Jak-stat, 2014
Inherited predisposition to myeloproliferative neoplasms.
Jones AV et al.
Therapeutic Advances in Hematology, 2013